Sudan I/OVA
Sudan I/OVA is an antigen-adjuvant conjugate formed by coupling Sudan I (HY-D0024) with Ovalbumin (OVA) . By conjugating the antigen with a protein adjuvant, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the main epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells.
Product Specifications
UNSPSC
12352200
Target
Biochemical Assay Reagents
Type
Biochemical Assay Reagents
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sudan-i-ova.html
Smiles
[SudanI/OVA]
References & Citations
[1]Weiss AM, et al. Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8+ T-cell response. Sci Rep. 2021 Mar 18;11 (1) :6267.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1411624-01 0.02 mg (E-Coli)
Recombinant Lactococcus lactis subsp. lactis Phosphoserine aminotransferase (serC)
Ask
View Details MBS1411624-02 0.02 mg (Yeast)
Recombinant Lactococcus lactis subsp. lactis Phosphoserine aminotransferase (serC)
Ask
View Details